Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections

1 - 15 of 299 Items

Research paper2024, dec 7

Stereotactic body radiotherapy results for de-novo extracranial oligometastatic cancer patients

Ipek Pinar Aral, Gonca Altınışık İnan, Suheyla Aytac Arslan, Ali Kerim Aksakal, Huseyin Furkan Ozturk, Yasin Caygın, Havva Beyaz, Muhammet Bülent Akıncı, Yılmaz Tezcan

Online first

Research paper

Research paper2024, dec 7
Research paper2024, dec 7
Research paper2024, nov 19

Carcinoma lung with cutaneous metastasis: experience from an Indian institute

Diptajit Paul, Sheeba Bhardwaj, Abhishek Soni, Ashok Chauhan, Rakesh Dhankhar, Paramjeet Kaur

Online first

Research paper

Review paper2024, nov 18

Targeted nanodelivery systems for personalized cancer therapy

Szymon Roszkowski, Zofia Durczynska, Sylwia Szablewska

Online first

Review paper

Review paper2024, nov 15

Monte Carlo methods to assess biological response to radiation in peripheral organs and in critical organs near the target

Natalia Matuszak, Igor Piotrowski, Marta Kruszyna-Mochalska, Agnieszka Skrobała, Mirosława Mocydlarz-Adamcewicz, Julian Malicki

Vol 29, No 5 (2024)

Review paper

DOI: 10.5603/rpor.103525
Rep Pract Oncol Radiother 2024;29(5):638-648.
Research paper2024, nov 5

Treatment of oropharyngeal cancer during the COVID-19 lockdown — outcomes for patients treated during the pandemic

Niall O'Dwyer, Liam O'Connell, Darragh Browne, Bahareh Khosravi, Sinead Brennan, Fran Duane, John Armstrong, Oleksandr Boychak, Orla McArdle

Vol 29, No 5 (2024)

Research paper

DOI: 10.5603/rpor.103236
Rep Pract Oncol Radiother 2024;29(5):606-613.
Letter to the Editor2024, nov 5

A cross-sectional study using the Surveillance, Epidemiology, and End Results Program database to estimate the prevalence of Myelodysplastic syndrome (MDS) in the United States

Shangyi Fu, Michel Adeniran, Zachrieh Alhaj, Diana Bonilla, Melissa Marchan-Martinez, Ibeth Caceres, Danny Huynh

Online first

Letter to the Editor

Review paper2024, nov 5

Prehabilitation approaches for gastrointestinal cancer surgery: a narrative review

Sergii Girnyi, Luigi Marano, Jaroslaw Skokowski, Piotr Mocarski, Witold Kycler, Gaetano Gallo, Agnieszka Dyzmann-Sroka, Karolina Kazmierczak-Siedlecka, Leszek Kalinowski, Tomasz Banasiewicz, Karol Polom

Vol 29, No 5 (2024)

Review paper

DOI: 10.5603/rpor.103136
Rep Pract Oncol Radiother 2024;29(5):614-626.
Research paper2024, oct 31

Ultra-low dose rate brachytherapy (uLDR-BT) in treatment of patients with unfavorable intermediate-risk group prostate cancer — retrospective analysis

Adam Kluska, Artur Chyrek, Wojciech Maria Burchardt, Marcin Włodarczyk, Grzegorz Bielęda, Adam Chicheł

Vol 29, No 5 (2024)

Research paper

DOI: 10.5603/rpor.103135
Rep Pract Oncol Radiother 2024;29(5):600-605.
Clinical vignette2024, oct 16

Local chemotherapy with conjunctival bevacizumab injections in case of lymphoma tumor

Piotr Fryczkowski

Vol 29, No 5 (2024)

Clinical vignette

DOI: 10.5603/rpor.102880
Rep Pract Oncol Radiother 2024;29(5):661-665.
Research paper2024, oct 16

Correlation of degree of acute radiation dermatitis (RD) with skin dose distribution in head and neck squamous cell carcinoma patients treated with definitive concurrent chemoradiation

Sattwik Basu, I Subrata Chatterjee, Kaustav Chatterjee, Sattama Samanta, Solanki Saha, Sk Toslim Hossain, Pritha Mondal, Shyamal Biswas

Vol 29, No 5 (2024)

Research paper

DOI: 10.5603/rpor.102824
Rep Pract Oncol Radiother 2024;29(5):579-587.
Letter to the Editor2024, oct 15

An omics-based tumor microenvironment approach and its prospects

Rajeev Nema

Vol 29, No 5 (2024)

Letter to the Editor

DOI: 10.5603/rpor.102823
Rep Pract Oncol Radiother 2024;29(5):649-650.
Research paper2024, oct 15

Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial for Randomized Controlled Trial Patients with Metastatic Spine Disease

Ulysses G. Gardner Jr, Melissa M. Brately, Raed Zuhour, Yilun Sun, Daniel E. Spratt, Shearwood McClelland III

Vol 29, No 5 (2024)

Research paper

DOI: 10.5603/rpor.102822
Rep Pract Oncol Radiother 2024;29(5):657-660.
Letter to the Editor2024, oct 15

Can the reprogrammed cancer cells serve as an alternative source of (induced) cancer stem cells?

Ewelina Stelcer, Małgorzata Blatkiewicz, Karol Jopek, Wiktoria Maria Suchorska, Marcin Rucinski

Vol 29, No 5 (2024)

Letter to the Editor

DOI: 10.5603/rpor.102821
Rep Pract Oncol Radiother 2024;29(5):651-656.